Syringes with Permanently Attached Safety Needles
ID: IAD-2411-72Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/e7009da6e22e4f1db5e07deaf70338a0/view
Timeline
  1. 1
    Posted Mar 13, 2025, 12:00 AM UTC
  2. 2
    Updated Mar 13, 2025, 12:00 AM UTC
  3. 3
    Due Mar 27, 2025, 9:00 PM UTC
Description

The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking qualified vendors to provide syringes with permanently attached safety needles for Military Treatment Facilities (MTFs) within the Military Health System (MHS). This procurement aims to standardize medical supplies and ensure safety in medical practices, with an estimated annual demand of approximately $268,297.12 based on recent usage data across various military branches. Interested vendors must be listed on the Qualified Suppliers List (QSL MN-2403-11) and submit discounted pricing quotes below Distribution and Pricing Agreement (DAPA) rates by 5:00 PM local Philadelphia time on March 27, 2025, with the anticipated selection date set for April 25, 2025. For further inquiries, vendors may contact Mr. Arthur Redmond at arthur.b.redmond.ctr@health.mil or Mr. David Sheaffer at david.v.sheaffer.ctr@health.mil.

Point(s) of Contact
Mr. Arthur Redmond MMESO Data Analyst Contractor
arthur.b.redmond.ctr@health.mil
Mr. David Sheaffer MMESO Project Manager Contractor
david.v.sheaffer.ctr@health.mil
Files
Title
Posted
IA Announcement IAD-2411-72 SYRINGES WITH PERMANENTLY ATTACHED SAFETY NEEDLES.docx
Mar 13, 2025, 1:05 PM UTC
The Defense Health Agency (DHA) and the Defense Logistics Agency (DLA) are initiating a Standardization Action for the procurement of Syringes with Permanently Attached Safety Needles targeted at Military Treatment Facilities (MTFs) within the Military Health System (MHS). This initiative is open to vendors listed on the Qualified Suppliers List (QSL MN-2403-11) who can submit discounted pricing quotes based on Distribution and Pricing Agreement (DAPA) rates. The anticipated selection date is April 25, 2025, with a five-year agreement for the chosen vendor, who is expected to support the government's goal of standardizing medical materials. The document requires interested vendors to respond via email with comprehensive company and pricing information and specifies that pricing must be below DAPA rates. The total estimated annual demand for the syringes is approximately $268,297.12, derived from recent usage data across various military branches. It details vendor responsibilities, including submission deadlines and requirements for validation of pricing. Selected vendors should be prepared for inventory distribution through DoD Medical/Surgical Prime Vendors, emphasizing the importance of compliance with outlined standards. Overall, this document serves as a framework for the acquisition process of specified medical supplies, ensuring evaluation based on cost-effectiveness while promoting operational and institutional needs of the military healthcare system.
IA Package Worksheet IAD-2411-72 SYRINGES WITH PERMANENTLY ATTACHED SAFETY NEEDLES.xlsx
Mar 13, 2025, 1:05 PM UTC
The document outlines the Vendor IA Pricing Submission Form for the Medical Materiel Enterprise Standardization Office (MMESO), specifically for the procurement of syringes with permanently attached safety needles (SA Product Group: IAD-2411-72). It requires vendors to provide accurate pricing that reflects Prime Vendor costs and includes a range of detailed product specifications. Vendors must submit full pricing offers and their qualifications by the specified due date; only those listed on the Qualified Supplier List (QSL) for these products will be considered. Included are several fields for detailed vendor information, product descriptions, and pricing structures including unit prices, incentives, and packaging details. Key product examples comprise various types of sterile syringes, each identified by gauge and packaging specifications. The aim is to ensure standardization and efficiency in supplying medical materials to the Department of Defense and its partners. This initiative illustrates the government’s commitment to maintaining safety standards in medical supplies while managing procurement processes effectively.
Lifecycle
Title
Type
Syringes with Permanently Attached Safety Needles
Currently viewing
Combined Synopsis/Solicitation
Similar Opportunities
Specimen Container Peel Pack
Buyer not available
The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
Skin Markers
Buyer not available
The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Skin Markers, with a Sources Sought notification anticipated around May 1, 2025. This initiative aims to identify suppliers of sterile and non-sterile skin marking devices that meet stringent medical standards, including the use of non-toxic, biocompatible ink and compliance with Trade Agreements Act regulations. These skin marking devices are essential in medical settings for accurate patient care and procedural documentation. Interested vendors must secure a Distribution and Pricing Agreement (DAPA) and ensure their registration in the System for Award Management (SAM) to participate. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization team at dha.detrick.med-log.mbx.mmeso@health.mil.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
Knee Sleeves, Compression
Buyer not available
The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking qualified vendors to provide Compression Knee Sleeves as part of a Sources Sought notification aimed at establishing a Qualified Suppliers Listing (QSL). This initiative is intended to support Military Treatment Facilities (MTFs) within the Military Health System (MHS) and is expected to lead to a standardization action by April 2025, with an estimated annual sales volume of approximately $471,847 for the product line. Vendors must meet specific requirements, including having a Distribution and Pricing Agreement (DAPA), compliance with the Trade Agreements Act, and adherence to FDA regulations, while providing detailed product specifications and documentation. Interested vendors should submit their QSL Package Worksheet and supporting documentation by April 3, 2025, to the designated contacts, Ms. Rashida Winestock and Mr. David Sheaffer, at the provided email addresses.
Vaginal Specula Disposable
Buyer not available
The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
Skin Staplers
Buyer not available
The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Skin Staplers, with a presolicitation notice expected to be released on or about February 9, 2025. This initiative aims to solicit information and products for evaluation, focusing on sterile, single patient use skin staplers designed for external skin closure, while excluding reloadable, reprocessed, absorbable, or rotating head staplers. The selected products must comply with the Trade Agreements Act (TAA) and be manufactured in compliant countries, with all vendors required to have a Distribution and Pricing Agreement (DAPA) and an active account in the System for Award Management (SAM). For further details, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or refer to the DLA website for additional information regarding the MSPV program.
Integrated Power Injection Catheters
Buyer not available
The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Integrated Power Injection Catheters, with a presolicitation notice expected to be released around May 15, 2025. This initiative aims to solicit information and products for evaluation, focusing on catheters that are preassembled, sterile, single-use, and disposable, featuring a maximum pressure rating of at least 325 PSI and a passive safety system. These catheters are critical for providing peripheral vascular access for administering fluids, medications, and blood products. Interested vendors must have a Distribution and Pricing Agreement (DAPA) and ensure compliance with Trade Agreements Act (TAA) requirements, with further details to be provided in the upcoming QSL Announcement available on SAM.gov. For inquiries, vendors can contact MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@health.mil or Tara J. Perrien at tara.perrien@dla.mil.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotations for a Blanket Purchase Agreement (BPA) related to the Pharmacy Uniform Formulary and the Uniform Formulary Additional Discount Program. This procurement aims to secure pharmaceutical agents for inclusion in the DoD's integrated pharmacy benefits program, focusing on enhancing medication management for service members while ensuring cost-effectiveness and compliance with established pricing protocols. The initiative is particularly significant for managing high-value medications, such as those used in breast cancer treatment, and emphasizes the importance of accurate data representation and adherence to procedural changes within the Military Health System. Interested vendors must submit their quotes by March 20, 2025, and can direct inquiries to Tracy Banks at tracy.e.banks2.civ@health.mil or Julianne Canaley at julianne.m.canaley.ctr@health.mil.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is issuing a Request for Quotation (RFQ) for pharmaceutical agents to be included in the Uniform Formulary under the TRICARE pharmacy benefit. This procurement aims to evaluate the clinical and cost-effectiveness of medications, allowing manufacturers to submit quotes for both the Uniform Formulary Blanket Purchase Agreement (UF BPA) and the Uniform Formulary Additional Discount Program (UF ADP). The selected pharmaceutical agents will be utilized in Military Treatment Facilities (MTFs) and the TRICARE retail network, emphasizing the importance of providing effective healthcare solutions while managing costs. Interested manufacturers must submit their quotes by March 20, 2025, and can direct inquiries to Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil or Tracy Banks at tracy.e.banks2.civ@health.mil.
Miniaturized Large Volume Infusion System
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking information from vendors regarding a Miniaturized Large Volume Infusion System as part of a Request for Information (RFI) numbered HT9425-25-RFI-MMCIP. The system must meet specific requirements, including the capability to deliver multiple fluids and medications simultaneously, compact size and weight restrictions, and compliance with FDA approvals, while also being suitable for both military and civilian applications. This initiative is crucial for enhancing patient care in military settings, particularly in austere environments, and aims to refine procurement requirements based on industry feedback. Interested vendors should submit their detailed responses by March 28, 2025, and can contact Katherine Ramsburg at katherine.j.ramsburg.civ@health.mil or 301-619-2651 for further information.